Regencell Bioscience Holdings Ltd (RGC) — Financial Flexibility Index
Regencell Bioscience Holdings Ltd (RGC) has a Financial Flexibility Index of -9.10x as of June 2024. Free cash flow of $-2.00 Million (operating CF $-2.00 Million minus capex $2.69K) represents -9% of total liabilities ($219.51K). Also explore how fast is Regencell Bioscience Holdings Ltd growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Regencell Bioscience Holdings Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Regencell Bioscience Holdings Ltd across 23 annual periods. Check how strategically is Regencell Bioscience Holdings Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Regencell Bioscience Holdings Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Regencell Bioscience Holdings Ltd. For the full company profile including market capitalisation, see Regencell Bioscience Holdings Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.31x | $-2.96 Million | $-3.11 Million | $895.31K | ▲ +81.8% |
| 2024 | -18.21x | $-4.00 Million | $-4.00 Million | $219.51K | ▼ -133.2% |
| 2023 | -7.81x | $-4.94 Million | $-4.96 Million | $632.32K | ▼ -63.2% |
| 2022 | -4.78x | $-4.49 Million | $-5.27 Million | $938.03K | ▼ -153034.6% |
| 2021 | 0.00x | $13.56K | $-767.31K | $4.34 Million | ▲ +101.6% |
| 2020 | -0.19x | $-608.74K | $-726.57K | $3.16 Million | ▼ -46.6% |
| 2019 | -0.13x | $-273.15K | $-390.99K | $2.08 Million | ▼ -173.5% |
| 2018 | 0.18x | $660.30 Million | $409.90 Million | $3.70 Billion | ▼ -0.5% |
| 2017 | 0.18x | $625.40 Million | $410.50 Million | $3.48 Billion | ▲ +1.6% |
| 2016 | 0.18x | $620.10 Million | $434.40 Million | $3.51 Billion | ▲ +19.9% |
| 2015 | 0.15x | $505.90 Million | $349.10 Million | $3.43 Billion | ▲ +9.7% |
| 2014 | 0.13x | $459.00 Million | $346.90 Million | $3.42 Billion | ▼ -10.4% |
| 2013 | 0.15x | $435.80 Million | $346.60 Million | $2.91 Billion | ▼ -0.8% |
| 2012 | 0.15x | $440.30 Million | $353.10 Million | $2.91 Billion | ▲ +26.0% |
| 2011 | 0.12x | $357.80 Million | $259.40 Million | $2.98 Billion | ▼ -33.4% |
| 2010 | 0.18x | $519.60 Million | $410.80 Million | $2.88 Billion | ▲ +89.5% |
| 2009 | 0.10x | $270.00 Million | $270.00 Million | $2.84 Billion | ▼ -67.3% |
| 2008 | 0.29x | $800.00 Million | $800.00 Million | $2.75 Billion | ▲ +137.9% |
| 2007 | 0.12x | $304.00 Million | $304.00 Million | $2.49 Billion | ▼ -20.9% |
| 2006 | 0.15x | $386.00 Million | $386.00 Million | $2.50 Billion | ▼ -1.5% |
| 2005 | 0.16x | $387.00 Million | $387.00 Million | $2.47 Billion | ▼ -45.0% |
| 2004 | 0.28x | $476.00 Million | $476.00 Million | $1.67 Billion | ▼ -21.0% |
| 2003 | 0.36x | $373.00 Million | $373.00 Million | $1.04 Billion | — |